A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial
- Author
- BiotechTV
- Published
- Tue 19 Nov 2024
- Episode Link
- https://podcasters.spotify.com/pod/show/biotechtv8/episodes/A-patient-advocacy-group-founded-by-two-parents-has-partnered-with-a-biotech-company-on-a-gene-therapy-for-limb-girdle-muscular-dystrophy-Type-2CR5---it-was-just-cleared-to-start-a-clinical-trial-e2v04l5
Dion Foundation Co-Founder and President Courtney Dion discusses with Atamyo Therapeutics CEO Stéphane Degove the many ways that patient advocate groups can support the work that biotech companies do.
